Hadas Tamar Pahima

Title: Hadas Tamar Pahima: Innovator in Cancer Treatment

Introduction

Hadas Tamar Pahima is a notable inventor based in Ahuzam, Israel. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 2 patents, Pahima is recognized for his work in developing methods that target specific cancer types.

Latest Patents

Pahima's latest patents focus on the use of hexokinase 2 (HK2)/mitochondria-detaching compounds for treating HK2-expressing cancers. The first patent outlines methods for utilizing these compounds, including jasmonate derivatives and piperazine derivatives, to treat, inhibit, or suppress HK2-expressing cancers. This invention provides a promising approach to cancer therapy by targeting the metabolic pathways of cancer cells.

Career Highlights

Hadas Tamar Pahima is currently associated with Vidac Pharma Ltd., where he continues to advance his research in cancer treatment. His work is characterized by a commitment to developing effective pharmaceutical compositions that can significantly impact patient outcomes.

Collaborations

Pahima collaborates with talented individuals in his field, including Reut Yosef Hamo and Vered Behar. Their combined expertise contributes to the innovative environment at Vidac Pharma Ltd., fostering advancements in cancer research.

Conclusion

Hadas Tamar Pahima is a pioneering inventor whose work in cancer treatment is making a difference in the medical field. His innovative patents and collaborations highlight his dedication to improving therapeutic options for patients.